TVRD·140755307·US·equity·Healthcare - Biotechnology-Activist
TVRD (TVARDI THERAPEUTICS INC) is held by 37 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.2M), GEODE CAPITAL MANAGEMENT, LLC ($579,957), SILVERCREST ASSET MANAGEMENT GROUP LLC ($321,288). Net institutional sentiment: Mixed.
See how TVRD's score breaks down across 4 SEC sources
Showing 1-20 of 45
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer